company background image
BOUL logo

Boule Diagnostics OM:BOUL 株式レポート

最終価格

kr10.60

時価総額

kr411.6m

7D

-3.6%

1Y

0%

更新

19 Jun, 2024

データ

会社財務 +

Boule Diagnostics AB (publ)

OM:BOUL 株式レポート

時価総額:kr411.6m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

BOUL 株式概要

ブーレ・ダイアグノスティックスAB(publish)は、米国、アジア、東欧、中南米、西欧、アフリカ、中東において、血液診断用機器および消耗品の開発、製造、販売を行っている。

BOUL fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance5/6
Financial Health5/6
Dividends0/6

Boule Diagnostics AB (publ) 競合他社

価格と性能

Summary of all time highs, changes and price drops for Boule Diagnostics
Historical stock prices
Current Share Pricekr10.60
52 Week Highkr12.62
52 Week Lowkr8.66
Beta0.53
1 Month Change6.00%
3 Month Change5.79%
1 Year Change0%
3 Year Change-80.66%
5 Year Change-79.73%
Change since IPO-9.59%

最新ニュース

Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Jun 06
Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

May 10
Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Recent updates

Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Jun 06
Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

May 10
Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Mar 20
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Feb 09
Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Dec 30
Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Jul 25
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

May 26
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Jul 26
Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

Jul 19
Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Mar 06
We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Feb 03
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Apr 29
The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Apr 09
Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Mar 25
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Mar 07
Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

Feb 17
Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Jan 30
These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

Jan 14
Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Dec 28
How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Dec 10
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

Nov 22
What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

株主還元

BOULSE Medical EquipmentSE 市場
7D-3.6%-3.0%-1.1%
1Y0%-2.2%13.9%

業界別リターン: BOUL過去 1 年間で-2.2 % の収益を上げたSwedish Medical Equipment業界を上回りました。

リターン対市場: BOULは、過去 1 年間で13.9 % のリターンを上げたSwedish市場を下回りました。

価格変動

Is BOUL's price volatile compared to industry and market?
BOUL volatility
BOUL Average Weekly Movement5.8%
Medical Equipment Industry Average Movement7.0%
Market Average Movement5.9%
10% most volatile stocks in SE Market12.6%
10% least volatile stocks in SE Market3.5%

安定した株価: BOUL過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: BOULの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1956200Torben Nielsenwww.boule.com

ブーレ・ダイアグノスティックスAB(publish)は、米国、アジア、東欧、中南米、西欧、アフリカ、中東において、血液診断用機器および消耗品の開発、製造、販売を行っている。Swelab、Medonic、Quintusブランドで血液学分析装置、試薬、コントロール、キャリブレーターを、Exigoブランドで動物用血液学および臨床化学分析装置システム、試薬、パネルを提供している。中小規模の病院、診療所、検査室、動物病院、その他の診断会社にサービスを提供している。Boule Diagnostics AB(publ)は1956年に設立され、スウェーデンのスポンガに本社を置く。

Boule Diagnostics AB (publ) 基礎のまとめ

Boule Diagnostics の収益と売上を時価総額と比較するとどうか。
BOUL 基礎統計学
時価総額kr411.63m
収益(TTM)kr26.88m
売上高(TTM)kr576.03m

15.3x

PER(株価収益率

0.7x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
BOUL 損益計算書(TTM)
収益kr576.03m
売上原価kr324.02m
売上総利益kr252.01m
その他の費用kr225.14m
収益kr26.88m

直近の収益報告

Mar 31, 2024

次回決算日

Jul 22, 2024

一株当たり利益(EPS)0.69
グロス・マージン43.75%
純利益率4.67%
有利子負債/自己資本比率31.5%

BOUL の長期的なパフォーマンスは?

過去の実績と比較を見る